Sundeep K. (Rob) Addy

Pioneer Hi-Bred International v. Agrigenetics, Inc. (S.D. Ind. 2009-2011)
Trial counsel for Pioneer in a dispute with Agrigenetics and its parent Dow AgroSciences concerning the marketing of Pioneer seed genetics through particular distribution channels. Case settled during trial after Pioneer prevailed on a Daubert challenge to Plaintiffs’ damages expert, and after openings and cross examination of plaintiffs’ first witness.

ICE Corporation v. Hamilton Sundstrand Corporation et al. (10th Cir., 2010-2011)
Counsel for Hamilton Sundstrand and Ratier-Figeac in appeal of adverse jury verdict on a misappropriation of trade secrets claim under Kansas law. Successfully obtained reversal of $9 million punitive damages award. Case currently on remand.

Bayer Schering Pharma et al. v. Barr Laboratories (D.N.J., 2007-2009)
Trial counsel for Bayer Schering in Hatch-Waxman litigation against challenger seeking to market generic version of leading oral contraceptive Yasmin®. Bench trial held November-December 2007. Ruling in favor of Barr at trial level. Affirmed 2-1 by Federal Circuit with dissent by Judge Newman. 

Applied Medical Resources Co. v. U.S. Surgical Corp. et al. (C.D. Cal, 2005-2008)
Represented defendant United States Surgical Corporation, a subsidiary of Covidien, in pretrial-phase of patent infringement suit. Applied Medical alleged that U.S. Surgical infringed a medical device patent and sought up to $300 million in damages and an injunction. Bartlit Beck trial team eventually won non-infringement jury verdict after five-week trial, which was affirmed unanimously on appeal to the Federal Circuit. Prior to Bartlit Beck’s representation, U.S. Surgical had twice previously been found to willfully infringe the same patent.

American Airlines v. Sabre Inc. et al. (N.D. Tex., Tarrant County, Tex., 2011-Present)
Trial counsel for Sabre in breach of contract and antitrust actions relating to the display of American’s fares in Sabre’s Global Distribution System.

U.S. Airways v. Sabre Inc. et al. (S.D.N.Y., 2011-Present)
Trial counsel for Sabre in breach of contract and antitrust actions relating to the display of U.S. Airways’ fares in Sabre’s Global Distribution System.

Bayer Schering Pharma et al. v. Watson Laboratories et al. (D. Nev., 2007-Present)
Trial counsel for Bayer Schering in Hatch-Waxman litigation against challengers seeking to market generic versions of oral contraceptive YAZ®. Cases pending.

Bayer Schering Pharma AG v. Sandoz, Inc. et al. (S.D.N.Y., 2007-Present)
Trial counsel for Bayer Schering in Hatch-Waxman litigation against challengers seeking to market generic versions of oral contraceptives Yasmin® and YAZ®. Cases pending.

Mercury Companies, Inc. et al. v. The First American Company et al. (D. Colo. 2008-2010)
Represented counter-defendant Fidelity National Financial, Inc. and four plaintiff title agents in breach of contract and tortious interference action. The plaintiff title agents alleged breach of contract against defendants. Defendants allege that Fidelity tortiously interfered with defendants’ attempted purchase of the four title agents. Case settled favorably after preliminary injunction phase.

In re Generically Modified Rice Litigation (E.D. Mo., 2008-Present)
Represented Bayer CropScience LP during class-certification phase of multi-district litigation concerning alleged presence of genetically engineered rice in commercial rice shipments. Successfully obtained ruling denying class certification from District Court. Eighth Circuit denied interlocutory appeal. 

Hoover Co. v. Bissell Homecare, Inc. (N.D. Ill., 2007)
Represented BISSELL in false advertising claims pending in federal court in Illinois and Michigan. Case settled night before opening statements in preliminary injunction trial.

Natterman et al. v. Bayer Corp. et al. (E.D. Pa., 2006-2007)
Trial counsel for Bayer in and patent litigation relating to recombinant Factor VIII concentrates used in treatment of hemophilia. Cases settled on very favorable terms immediately after Bayer won motion for early bifurcated trial of Bayer’s affirmative license defense.